• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

协同转运蛋白寡聚化:涉及蛋白激酶 C 和蛋白磷酸酶 1 的新型调节和功能机制。

Oligomerization of equilibrative nucleoside transporters: a novel regulatory and functional mechanism involving PKC and PP1.

机构信息

Department of Chemistry and Biology, Ryerson University, Toronto, Ontario, Canada.

Department of Biochemistry and Molecular Biomedicine, Institute of Biomedicine, University of Barcelona, Barcelona, Spain.

出版信息

FASEB J. 2019 Mar;33(3):3841-3850. doi: 10.1096/fj.201800440RR. Epub 2018 Dec 6.

DOI:10.1096/fj.201800440RR
PMID:30521377
Abstract

Equilibrative nucleoside transporters (ENTs) translocate nucleosides and nucleobases across plasma membranes, as well as a variety of anti-cancer, -viral, and -parasite nucleoside analogs. They are also key members of the purinome complex and regulate the protective and anti-inflammatory effects of adenosine. Despite their important role, little is known about the mechanisms involved in their regulation. We conducted membrane yeast 2-hybrid and coimmunoprecipitation studies and identified, for the first time to our knowledge, the existence of protein-protein interactions between human ENT1 and ENT2 (hENT1 and hENT2) proteins in human cells and the formation of hetero- and homo-oligomers at the plasma membrane and the submembrane region. The use of NanoLuc Binary Technology allowed us to analyze changes in the oligomeric status of hENT1 and hENT2 and how they rapidly modify the uptake profile for nucleosides and nucleobases and allow cells to respond promptly to external signals or changes in the extracellular environment. These changes in hENTs oligomerization are triggered by PKC activation and subsequent action of protein phosphatase 1.-Grañe-Boladeras, N., Williams, D., Tarmakova, Z., Stevanovic, K., Villani, L. A., Mehrabi, P., Siu, K. W. M., Pastor-Anglada, M., Coe, I. R. Oligomerization of equilibrative nucleoside transporters: a novel regulatory and functional mechanism involving PKC and PP1.

摘要

平衡核苷转运体(ENTs)可将核苷和碱基跨质膜转运,以及各种抗癌、抗病毒和抗寄生虫核苷类似物。它们也是嘌呤体复合物的关键成员,调节腺苷的保护和抗炎作用。尽管它们的作用很重要,但对其调节机制知之甚少。我们进行了膜酵母 2 杂交和共免疫沉淀研究,首次在人类细胞中发现了人类 ENT1 和 ENT2(hENT1 和 hENT2)蛋白之间的蛋白-蛋白相互作用,并在质膜和亚膜区形成了异源和同源寡聚体。NanoLuc Binary Technology 的使用使我们能够分析 hENT1 和 hENT2 的寡聚状态的变化,以及它们如何快速改变核苷和碱基的摄取谱,使细胞能够迅速对外界信号或细胞外环境的变化做出反应。这些 hENTs 寡聚化的变化是由 PKC 激活和随后的蛋白磷酸酶 1 作用触发的。-Grañe-Boladeras,N.,Williams,D.,Tarmakova,Z.,Stevanovic,K.,Villani,L. A.,Mehrabi,P.,Siu,K. W. M.,Pastor-Anglada,M.,Coe,I. R. 平衡核苷转运体的寡聚化:一种涉及 PKC 和 PP1 的新型调节和功能机制。

相似文献

1
Oligomerization of equilibrative nucleoside transporters: a novel regulatory and functional mechanism involving PKC and PP1.协同转运蛋白寡聚化:涉及蛋白激酶 C 和蛋白磷酸酶 1 的新型调节和功能机制。
FASEB J. 2019 Mar;33(3):3841-3850. doi: 10.1096/fj.201800440RR. Epub 2018 Dec 6.
2
Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.在核苷转运体缺陷的PK15细胞中稳定表达的克隆人平衡核苷转运体ENT1和ENT2的动力学和药理学特性。ENT2对鸟苷和胞苷表现出低亲和力,但对肌苷表现出高亲和力。
J Biol Chem. 2000 Mar 24;275(12):8375-81. doi: 10.1074/jbc.275.12.8375.
3
Localization of human equilibrative nucleoside transporters, hENT1 and hENT2, in renal epithelial cells.人平衡核苷转运体hENT1和hENT2在肾上皮细胞中的定位
Am J Physiol Renal Physiol. 2003 May;284(5):F902-10. doi: 10.1152/ajprenal.00215.2002. Epub 2003 Jan 14.
4
Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiae.酿酒酵母中产生的人类平衡核苷转运蛋白1和2的尿苷识别基序。
Nucleosides Nucleotides Nucleic Acids. 2004;23(1-2):361-73. doi: 10.1081/ncn-120028333.
5
Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.平衡核苷转运蛋白hENT1的甘氨酸154对于核苷转运以及赋予对抑制剂硝基苄硫肌苷、双嘧达莫和地拉齐普的敏感性很重要。
Biochem Pharmacol. 2004 Feb 1;67(3):453-8. doi: 10.1016/j.bcp.2003.09.018.
6
Insulin restores glucose inhibition of adenosine transport by increasing the expression and activity of the equilibrative nucleoside transporter 2 in human umbilical vein endothelium.胰岛素通过增加人脐静脉内皮细胞中平衡核苷转运体2的表达和活性,恢复葡萄糖对腺苷转运的抑制作用。
J Cell Physiol. 2006 Dec;209(3):826-35. doi: 10.1002/jcp.20769.
7
Equilibrative nucleoside transporter 2 is expressed in human umbilical vein endothelium, but is not involved in the inhibition of adenosine transport induced by hyperglycaemia.平衡核苷转运体2在人脐静脉内皮中表达,但不参与高血糖诱导的腺苷转运抑制。
Placenta. 2005 Sep-Oct;26(8-9):641-53. doi: 10.1016/j.placenta.2004.10.006. Epub 2004 Dec 15.
8
Effect of hypoxia on human equilibrative nucleoside transporters hENT1 and hENT2 in breast cancer.缺氧对乳腺癌患者人嘧啶核苷转运蛋白 1(hENT1)和人嘧啶核苷转运蛋白 2(hENT2)的影响。
FASEB J. 2019 Dec;33(12):13837-13851. doi: 10.1096/fj.201900870RR. Epub 2019 Oct 10.
9
Development of a Novel HEK293 Cell Model Lacking to Study the Pharmacology of Endogenous -Encoded Equilibrative Nucleoside Transporter Subtype 2.开发一种新型 HEK293 细胞模型以研究内源性编码的核苷转运蛋白亚型 2 的药理学。
Drug Metab Dispos. 2024 Sep 16;52(10):1094-1103. doi: 10.1124/dmd.124.001814.
10
Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).用于研究平衡核苷转运体1和2(ENT1和ENT2)的地拉卓类似物。
Bioorg Med Chem Lett. 2014 Dec 15;24(24):5801-5804. doi: 10.1016/j.bmcl.2014.10.026. Epub 2014 Oct 28.

引用本文的文献

1
Oligomerization of drug transporters: Forms, functions, and mechanisms.药物转运体的寡聚化:形式、功能及机制
Acta Pharm Sin B. 2024 May;14(5):1924-1938. doi: 10.1016/j.apsb.2024.01.007. Epub 2024 Jan 20.
2
The Impact of Dipyridamole on Disease-Associated Microglia Phenotypic Transformation in White Matter Lesions Induced by Chronic Cerebral Hypoperfusion.双嘧达莫对慢性脑低灌注诱导的脑白质病变中与疾病相关的小胶质细胞表型转化的影响。
Neurochem Res. 2024 Mar;49(3):744-757. doi: 10.1007/s11064-023-04066-9. Epub 2023 Dec 15.
3
Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes ( and ).
先天性核苷转运体(NT)编码基因( 和 )缺陷。
Int J Mol Sci. 2022 Aug 7;23(15):8770. doi: 10.3390/ijms23158770.
4
EndoBind detects endogenous protein-protein interactions in real time.EndoBind 实时检测内源性蛋白质-蛋白质相互作用。
Commun Biol. 2021 Sep 15;4(1):1085. doi: 10.1038/s42003-021-02600-5.
5
Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine.克拉屈滨的转运体底物、抑制剂和诱导剂特性综述。
Clin Pharmacokinet. 2021 Dec;60(12):1509-1535. doi: 10.1007/s40262-021-01065-3. Epub 2021 Aug 26.
6
Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma.hENT1 和 dCK 在神经鞘瘤中吉西他滨敏感性和恶性中的作用。
Neuro Oncol. 2021 Jun 1;23(6):945-954. doi: 10.1093/neuonc/noab015.
7
Decreased Equilibrative Nucleoside Transporter 1 (ENT1) Activity Contributes to the High Extracellular Adenosine Levels in Mesenchymal Glioblastoma Stem-Like Cells.间质型神经胶质瘤干细胞样细胞中低水平的核苷转运蛋白 1(ENT1)活性导致细胞外高浓度腺苷水平。
Cells. 2020 Aug 18;9(8):1914. doi: 10.3390/cells9081914.
8
Bidirectional transport of 2-chloroadenosine by equilibrative nucleoside transporter 4 (hENT4): Evidence for allosteric kinetics at acidic pH.通过平衡核苷转运蛋白 4(hENT4)双向转运 2-氯腺苷:在酸性 pH 值下存在变构动力学的证据。
Sci Rep. 2019 Sep 19;9(1):13555. doi: 10.1038/s41598-019-49929-w.
9
Who Is Who in Adenosine Transport.腺苷转运领域的风云人物。
Front Pharmacol. 2018 Jun 14;9:627. doi: 10.3389/fphar.2018.00627. eCollection 2018.